FIELD: medicine.
SUBSTANCE: invention concerns medicine, namely to ophthalmology. It is offered to use a composition containing, at least one agonist BMP-4 for treatment of glaucoma. Thus administer the composition with immediate delivery into an eye of the patient, for example using local eye drops; an oculentum; devices of the slowed down release implanted into a cul-de-sac of an eye either about a sclera of an eye or in an eye; by means of an injection. Concentration of BMP-4 in the composition preferably makes from 0.01 to 2%. The method is based on property of BMP-4 to reduce an ophthalmotonus.
EFFECT: creation of a composition for glaucoma treatment.
8 cl, 15 dwg, 2 tbl, 1 ex
Authors
Dates
2008-10-27—Published
2002-10-31—Filed